Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis

Background and aim: Imaging guided microwave ablation (MWA) for hepatocellular carcinoma (HCC) has become a widely used method over recent years. Tumors close to the diaphragm, gastrointestinal tract, gallbladder, pancreas, hepatic hilum and major bile duct or vessels are generally considered relative contraindications for microwave ablation. This study was conducted to assess the effectiveness and safety of ultrasonography-guided MWA in treating patients with HCC in difficult anatomical sites in comparison to those in conventional sites. Patients and methods: Eighty-eight patients were included and divided into two groups: the study group of 44 with 46 lesions lying <5mm from the diaphragm, hepatic capsule, gall bladder (GB) or large vessel; and the control group of 44 patients with 50 lesions in non-risky sites. Each lesion was ablated using an ultrasound guided microwave probe using a detailed protocol. Results: Most of the patients were males, with a mean age of 57.8 years. In the study group, two patients had lesions adjacent to the GB, twelve were perivascular and 32 were subcapsular. The overall successful ablation rates were 84.8% and 92% in the study and control groups, respectively. Within the study group, ablation rates were 100%, 75% and 87.5% for lesions close to the GB, perivascular lesions and subcapsular lesions, respectively. One patient developed a subcutaneous abscess, with good outcome after proper treatment. Fever, pain and asymptomatic pleural effusion were reported after ablation without statistically significant difference between the groups or among subgroups. In conclusion: MWA for HCC in difficult anatomical sites is as effective and safe as for ordinary sites.

Differentiation of benign and malignant bowel lesions by transabdominal ultrasound using grey-scale and Doppler parameters.

BACKGROUND AND STUDY AIMS: The aim of this study was to assess the ability of transabdominal ultrasonographic morphologic features and Doppler flow parameters in differentiating benign from malignant bowel lesions. PATIENTS AND METHODS: Sixty patients with sonographically detected gastrointestinal lesions and 30 control subjects were prospectively enrolled. Bowel wall thickness; length of the affected segment; the wall layering pattern; the resistive index (RI); pulsatility index (PI); flow volume (FV) of the intramural vessels, the superior mesenteric artery (SMA), and the portal vein (PV) were recorded. The final diagnosis was histopathological. Biopsies were obtained endoscopically, ultrasound-guided, or by surgery. RESULTS: Of the patients, 48 proved to be histopathologically malignant and 12 were benign. Malignant bowel lesions were found to have a higher mean wall thickness (a cutoff value of 12.3mm), more frequent loss of wall layering pattern (88.2% vs. 38.9%), a shorter length of affected segment (11.2 vs. 49.2cm); P=0.001. The RI, PI of the intramural vessels and SMA showed no difference between the inflammatory and malignant groups. Ultrasound-guided biopsy was resorted to in 13 patients (21.7%) and it was diagnostic in all of them. CONCLUSION: Ultrasonography is helpful in the characterisation of bowel lesions suggesting their benign or malignant nature. Ultrasound-guided biopsy has certain indications. The Doppler parameters of different pathologies are overlapping and thus are of little help in this regard.